Medigene Ag

Heidelberg Pharma Gmbh

Eggert Stockfleth

Michael Kulke

Erwin Boehm

The present invention refers to a method for treating cancerous or precancerous lesions of the skin by administering a pharmaceutically effective amount of a polyphenol to a patient as well as to the production of a medicament thereto.

Use of a polyphenol for the treatment of a cancerous or pre-cancerous lesion of the skin

Use of a polyphenol for the treatment of a cancerous or precancerous lesion of the skin

A method for treating cancerous or pre-cancerous lesions of the skin by administering a pharmaceutically effective amount of a polyphenol to a patient as well as to the production of a medicament thereto is described herein.

The present invention is directed to the systemic administration of Fosfluridine Tidoxil, (5-fluorouridine)-5'-phosphoric acid (3-dodecylmercapto-2-decyloxy)propylester or a salt thereof, for the treatment of intraepithelial proliferative diseases such as actinic keratosis. The Fosfluridine Tidoxil can be systemically administered alone or in combination with topical treatment agents.

Growing community of inventors

Albersdorf, Germany

Eggert Stockfleth